Direct and Indirect Costs of AIDS in Belgium: A Preliminary Analysis

  • J. Lambert
  • G. Carrin
Part of the Health Systems Research book series (HEALTH)

Abstract

In this note, we present an analysis of direct and indirect costs of AIDS in Belgium. Direct costs comprise the costs of medical treatment and the non-personal costs of public information campaigns and other governmental assistance serving the general public. Indirect costs contain the costs of morbidity only. Incomplete information precluded us from also considering the indirect costs due to premature mortality.

Keywords

Income Sarcoma Interferon Zidovudine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ministerie van Economische Zaken (1988). Statistisch Overzicht van België 1988. Nationaal Instituut voor de Statistiek, Brussels.Google Scholar
  2. Ministerie van Economische Zaken (1988a). Sociale Statistieken, nr. 1, 79.Google Scholar
  3. Ministerie van Economische Zaken (1988b). Statistisch Tijdschrift 74 (3), 171.Google Scholar
  4. Scitovsky, A.A., Crine, M., and Lee, P.R. (1986). Medical care costs of patients with AIDS in San Fransisco. Journal of the American Medical Association 256 (22), 3103–3106.PubMedCrossRefGoogle Scholar
  5. Seage, G.R., Landers, S., Barry, M.A., Groopman, J., Lamb, G.A., and Epstein, A.M. (1986). Medical care costs of AIDS in Massachusetts. Journal of the American Medical Association 256 (22).Google Scholar

Copyright information

© ECSC-EEC-EAEC, Brussels-Luxembourg 1990

Authors and Affiliations

  • J. Lambert
  • G. Carrin

There are no affiliations available

Personalised recommendations